YAP1, a crucial member of the Hippo signaling pathway, and CK19, a marker of LCSCs, were highly expressed in the miR-135b-5p-high group, indicating that the Hippo signaling pathway was dysregulated and the stemness properties of tumor cells were more remarkable (Figure 4(c)) [30, 44]. The gene discussed is KRT19; the disease is neoplasm.